OFFICIAL PUBLICATION OF

by its subsidiary APPco

A time of shortages

Chris Brooker 31/01/2017

The TGA has provided updates on new and ongoing medicine shortages relevant to pharmacy The shortage warnings include: * There is limited availability of the hyperthyroidism treatment Neo-Mercazole (carbimazole) 5 mg tablets. The current shortage of the treatment, which is marketed in Australia by Amdipharm Mercury (Australia), is due to a delay in the manufacturing

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Funding secured for non-8CPA programs

Medschecks and Diabetes MedsCheck are included and funded under the 8CPA. The programs under the 8CPA will be undergoing a…

Anthony Tassone

Eli Lilly clarifies Mounjaro availability

One would think they could have made a commercial decision eith a needle maker to supply requisite number of needles…

Erin Threlfall

Funding secured for non-8CPA programs

This is a big step forward in securing the sustainability and viability of HMRs and RMMRs. Remember there is an…

Debbie Rigby

Funding secured for non-8CPA programs

So well done to the PSA for securing this funding. So important that these very valuable program finally gets looked…

Bente Hart

A time of shortages

Previous Forum: pharmacy does it for free!

Next Should the Easter Bunny come out to play now?

Shingles: managing a distressing skin condition

Impetigo: cause and treatment

Topical retinoids: versatile skin care ingredients

Ceramides: what are they and why are they important?

MENU

Previous Forum: pharmacy does it for free!

Next Should the Easter Bunny come out to play now?

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.